Literature DB >> 19725581

Benzothiopyranoindole-based antiproliferative agents: synthesis, cytotoxicity, nucleic acids interaction, and topoisomerases inhibition properties.

Lisa Dalla Via1, Sebastiano Marciani Magno, Ornella Gia, Anna Maria Marini, Federico Da Settimo, Silvia Salerno, Concettina La Motta, Francesca Simorini, Sabrina Taliani, Antonio Lavecchia, Carmen Di Giovanni, Giuseppe Brancato, Vincenzo Barone, Ettore Novellino.   

Abstract

Novel benzo[3',2':5,6]thiopyrano[3,2-b]indol-10(11H)-ones 1a-v were synthesized and evaluated for their antiproliferative activity in an in vitro assay of human tumor cell lines (HL-60 and HeLa). Compounds 1e-v, substituted at the 11-position with a basic side chain, showed a significant ability to inhibit cell growth with IC(50) values in the low micromolar range. Linear dichroism measurements showed that all 11-dialkylaminoalkyl substituted derivatives 1e-v behave as DNA-intercalating agents. Fluorimetric titrations demonstrated their specificity in binding to A-T rich regions, and molecular modeling studies were performed on the most active derivatives (1e, 1i, 1p) to characterize in detail the complexation mechanism of these benzothiopyranoindoles to DNA. A relaxation assay evidenced a dose-dependent inhibition of topoisomerase II activity that appeared in accordance with the antiproliferative capacity. Finally, for the most cytotoxic derivative, 1e, a topoisomerase II poisoning effect was also demonstrated, along with a weak inhibition of topoisomerase I-mediated relaxation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19725581     DOI: 10.1021/jm900627v

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Chiral ruthenium(II) anthraquinone complexes as dual inhibitors of topoisomerases I and II.

Authors:  Jun-Feng Kou; Chen Qian; Jin-Quan Wang; Xiang Chen; Li-Li Wang; Hui Chao; Liang-Nian Ji
Journal:  J Biol Inorg Chem       Date:  2011-08-21       Impact factor: 3.358

2.  Discovery of Pyrido[3',2':5,6]thiopyrano[4,3-d]pyrimidine-Based Antiproliferative Multikinase Inhibitors.

Authors:  Silvia Salerno; Elisabetta Barresi; Aída Nelly García-Argáez; Sabrina Taliani; Francesca Simorini; Giorgio Amendola; Stefano Tomassi; Sandro Cosconati; Ettore Novellino; Federico Da Settimo; Anna Maria Marini; Lisa Dalla Via
Journal:  ACS Med Chem Lett       Date:  2019-01-17       Impact factor: 4.345

3.  Phenylpyrazolo[1,5-a]quinazolin-5(4H)-one: a suitable scaffold for the development of noncamptothecin topoisomerase I (Top1) inhibitors.

Authors:  Sabrina Taliani; Isabella Pugliesi; Elisabetta Barresi; Silvia Salerno; Christophe Marchand; Keli Agama; Francesca Simorini; Concettina La Motta; Anna Maria Marini; Francesco Saverio Di Leva; Luciana Marinelli; Sandro Cosconati; Ettore Novellino; Yves Pommier; Roberto Di Santo; Federico Da Settimo
Journal:  J Med Chem       Date:  2013-09-16       Impact factor: 7.446

4.  Development of Conjugate Addition of Lithium Dialkylcuprates to Thiochromones: Synthesis of 2-Alkylthiochroman-4-ones and Additional Synthetic Applications.

Authors:  Shekinah A Bass; Dynasty M Parker; Tania J Bellinger; Aireal S Eaton; Angelica S Dibble; Kaata L Koroma; Sylvia A Sekyi; David A Pollard; Fenghai Guo
Journal:  Molecules       Date:  2018-07-15       Impact factor: 4.411

5.  Conjugate Addition of Grignard Reagents to Thiochromones Catalyzed by Copper Salts: A Unified Approach to Both 2-Alkylthiochroman-4-One and Thioflavanone.

Authors:  Tania J Bellinger; Teavian Harvin; Ti'Bran Pickens-Flynn; Nataleigh Austin; Samuel H Whitaker; Mai Ling C Tang Yuk Tutein; Dabria T Hukins; Nichele Deese; Fenghai Guo
Journal:  Molecules       Date:  2020-05-01       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.